@article{MAKHILLRJBS20083810688,
    title = {Maxillary Bone Necrosis Following the Use of Bisphosphonates in Patients with Cancer: Management and Case Series},
    journal = {Research Journal of Biological Sciences},
    volume = {3},
    number = {8},
    pages = {925-929},
    year = {2008},
    issn = {1815-8846},
    doi = {rjbsci.2008.925.929},
    url = {https://makhillpublications.co/view-article.php?issn=1815-8846&doi=rjbsci.2008.925.929},
    author = {Silvia Tortorici,Francesco Burruano,Luigi Caradonna,Maria Lidia Buzzanca and},
    keywords = {Bisphosphonates,bone necrosis,avascular necrosis of the jaw,cancer,case series},
    abstract = {Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.}
    }